Garofalo et al. found that LEPR expression rate was 51.5% in BC tissues of patients with lymph node metastasis, which was significantly higher than 41.2% in BC tissues of patients without lymph node metastasis [33]. The gene discussed is LEPR; the disease is metastatic malignant neoplasm in the lymph nodes.